Crossmark

Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis

Crossref DOI link: https://doi.org/10.1038/s41598-024-66155-1

Published Online: 2024-07-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tan, Boyu

Chen, Li

Yan, Sulan

Pan, Huijie

Zhang, Jingxian

Wei, Hongyan
Funding

Funding for this research was provided by:

Hunan Provincial Health Care Commission Research Program Project (202203012682)

Hunan Provincial Natural Science Foundation Joint Fund (2022JJ80066)
License Information

Text and Data Mining valid from 2024-07-02

Version of Record valid from 2024-07-02
More Information

Article History

Received: 29 January 2024

Accepted: 27 June 2024

First Online: 2 July 2024

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below